期刊
BRITISH JOURNAL OF PHARMACOLOGY
卷 171, 期 8, 页码 1854-1869出版社
WILEY
DOI: 10.1111/bph.12394
关键词
Alzheimer's disease; cancer; glycolysis; law of mass action; mitochondria; neurodegeneration
资金
- University of Kansas Alzheimer's Disease Center [P30-AG035982]
- Frank and Evangeline Thompson Alzheimer's Treatment Development Fund
Here we discuss a specific therapeutic strategy we call bioenergetic medicine'. Bioenergetic medicine refers to the manipulation of bioenergetic fluxes to positively affect health. Bioenergetic medicine approaches rely heavily on the law of mass action, and impact systems that monitor and respond to the manipulated flux. Since classically defined energy metabolism pathways intersect and intertwine, targeting one flux also tends to change other fluxes, which complicates treatment design. Such indirect effects, fortunately, are to some extent predictable, and from a therapeutic perspective may also be desirable. Bioenergetic medicine-based interventions already exist for some diseases, and because bioenergetic medicine interventions are presently feasible, new approaches to treat certain conditions, including some neurodegenerative conditions and cancers, are beginning to transition from the laboratory to the clinic. Linked ArticlesThis article is part of a themed issue on Mitochondrial Pharmacology: Energy, Injury & Beyond. To view the other articles in this issue visit
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据